BackgroundCheck.run
Search For

Bing Xi ZhuPhiladelphia, PA

Known as:
Bingxi Zhu
Related to:
Yu Chen 41 Zhe Z Zou 65 Ginny Chu 59

Bing Zhu Phones & Addresses

Philadelphia, PA   

New York, NY   

Get Report
Control this profile

Mentions for Bing Xi Zhu

Bing Zhu resumes & CV records

Resumes

Bing Zhu Photo 33

Managing Director

Location:
New York, NY
Work:
Ripplewood Advisors
Managing Director
Bing Zhu Photo 34

Managing Director

Location:
New York, NY
Work:
Ripplewood Advisors
Managing Director
Bing Zhu Photo 35

Bing Zhu

Skills:
Microsoft Office, Microsoft Word, Powerpoint, Microsoft Excel, C++, Windows, Outlook, Html, Sql
Bing Zhu Photo 36

Bing Zhu

Bing Zhu Photo 37

Bing Zhu

Bing Zhu Photo 38

Bing Zhu

Bing Zhu Photo 39

Bing Zhu

Bing Zhu Photo 40

Bing Zhu

Location:
United States

Publications & IP owners

Us Patents

Method For Diagnosing Neoplasia

US Patent:
2003004, Mar 6, 2003
Filed:
Apr 22, 2002
Appl. No.:
10/125823
Inventors:
Li Liu - North Wales PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Gary Piazza - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
International Classification:
G01N033/574
G01N001/30
G01N033/48
US Classification:
435/007230, 435/040500
Abstract:
This invention provides a method for diagnosing a patient with neoplasia.

Packaged Pharmaceuticals And Methods For Causing Compounds And Pharmaceutical Compositions To Be Used As Inhibitors Of Neoplastic Lesions

US Patent:
2003017, Sep 18, 2003
Filed:
Sep 20, 2002
Appl. No.:
10/251165
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Spring House PA, US
Gary Piazza - Doylestown PA, US
International Classification:
A61K031/00
G06F017/60
G01N033/574
US Classification:
435/007230, 514/001000, 705/003000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmacetical Compositions Containing Such Compounds

US Patent:
2004000, Jan 15, 2004
Filed:
Sep 24, 2002
Appl. No.:
10/253629
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:
C12Q001/00
A61K031/60
A61K031/415
US Classification:
435/004000, 514/165000, 514/406000
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Methods For Identifying Compounds For Inhibition Of Neoplastic Lesions, And Pharmaceutical Compositions Containing Such Compounds

US Patent:
2005024, Nov 3, 2005
Filed:
Jul 7, 2005
Appl. No.:
11/176073
Inventors:
Li Liu - Ambler PA, US
Bing Zhu - Mobile AL, US
Han Li - Yardley PA, US
W. Thompson - Doylestown PA, US
Rifat Pamukcu - Springhouse PA, US
Gary Piazza - Doylestown PA, US
International Classification:
C12Q001/42
A61K031/519
US Classification:
435021000, 514262100
Abstract:
This invention provides pharmaceutical compositions containing compounds for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but prefereably not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.

Method Of Using A Novel Phosphodiesterase In Pharmaceutical Screeing To Identify Compounds For Treatment Of Neoplasia

US Patent:
6200771, Mar 13, 2001
Filed:
Oct 15, 1998
Appl. No.:
9/173375
Inventors:
Li Liu - Northwales PA
Rifat Pamukcu - Spring House PA
W. Joseph Thompson - Doylestown PA
Gary A. Piazza - Doylestown PA
Han Li - Yardley PA
Bing Zhu - Mobile AL
Assignee:
Cell Pathways, Inc. - Hosham PA
International Classification:
C12Q 144
US Classification:
435 19
Abstract:
A method for identifying compounds useful for the treatment of neoplasia involves acertaining whether such compounds exhibit an ability to inhibit a PDE that is characterized by cGMP specificity, cooperative kinetic behavior and insensitivity to phosphorylation.

Isbn (Books And Publications)

Xin Wen Wu Bao Hu Fa Ji Shi Shi Tiao Li Wen Da

Author:
Bing Zhu
ISBN #:
7801821947

Possible Relatives

Dawei I Zhu  Dehua Zhu  Di Zhu  Dian C Zhu  Diana Zhu  Dong Zhu  Dongming Zhu  Bing B Li  Bing W Lin  Bing Liu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.